169263 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer; Specifically defined cancers leukemia
ORGANIC COMPOUNDS
#602Chronic lymphocytic leukemia cell line
#603Method for examining WT1-related disease
#604Methods for treating hematopoietic malignancies
#605METHODS AND COMPOSITIONS FOR TREATING T-CELL LEUKEMIA
#606CD38 as a prognostic indicator in chronic lymphocytic leukemia
#607DIAGNOSIS AND TREATMENT OF DISEASES OR DISORDERS ASSOCIATED WITH XENOTROPIC MURINE LEUKEMIA VIRUS
#608BIOMARKERS FOR MONITORING THE TREATMENT BY QUINAZOLINONE COMPOUNDS
#609Methods for detecting and monitoring circulating cancer stem cells
#610Compositions and Methods for the Treatment and Diagnosis of Cancer
#611Methods for diagnosis, prognosis and methods of treatment
#612Diagnosis and therapy of hematological malignancies
#613DETECTING AND CONTROLLING ABNORMAL HEMATOPOIESIS
#614Biomarkers for predicting response to immunosuppressive therapy
#615Method for the Diagnosis of Leukemia Using Caspase-3
#616Methods for phenotyping of leukemias
#617REPLICATION PROTEIN
#618Detection of gleevec resistance
#619Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
#620Diagnosis and treatment of diseased and damaged tissue
#621UBIQUITIN PROTEASOME SYSTEM PROFILING AND THE USE THEREOF IN CLINICAL APPLICATIONS FOR PROLIFERATIVE HEMATOLOGICAL DISORDERS
#622Use of CFH or ApoH as a biochemical diagnostic marker for complete remission in acute myeloid leukemia
#623METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
#624Tumor-targeting monoclonal antibodies to FZD10 and uses thereof
#625Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof
#626HEMATOPOIETIC CELLS EXPRESSING THE PROTEIN SUSD3 AND LIGANDS FOR THE PROTEIN SUSD3
#627COMPOSITIONS AND METHODS FOR CANCER GENE DISCOVERY
#628METHODS AND KITS FOR DETECTING TUMOR-SPECIFIC FUSION PROTEINS
#629Quantitative ZAP-70 assay
#630Ex vivo methods for targeting or depleting acute myeloid leukemia cancer stem cells
#631Use of nanopatterned surfaces and method for enriching or isolating cellular subpopulations
#632Method of detecting leukemic cell
#633Diagnostic and Therapeutic Utility of Tribbles-2 in Human Cancers
#634COMPOSITIONS INCLUDING TRICIRIBINE AND EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR COMPOUNDS OR SALTS THEREOF AND METHODS OF USE THEREOF
#635Method for Preparation of Extract from Angelica Gigas Nakai and Composition Containing the Extract
#636ACCURACY FLUORESCENCE IN-SITU HYBRIDIZATION ASSAY OF SAMPLES WITH APOPTOTIC CELLS
#637Methods for use with BAFF antagonists
#638Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias
#639HUMANIZED ANTI-HUMAN CD34 ANTIBODY, THE PREPARATION METHOD AND USES THEREOF
#640Methods for providing personalized medicine test ex vivo for hematological neoplasms
#641METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#642Hematopoietic Lineage Cell Specific Protein (HS1) as a Marker for Lymphoid Malignancy
#643CALCIUM FLUX AS A PHARMACOEFFICACY BIOMARKER FOR INHIBITORS OF HISTONE DEACETYLASE
#644Leukemic cell CNS infiltration controlled by notch-induced chemotaxis
#645DIFFERENTIAL DIAGNOSIS OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
#646Identification and isolation of transitional cell carcinoma stem cells
#647Composite Profiles of Cell Antigens and Target Signal Transduction Proteins for Analysis and Clinical Management of Hematologic Cancers
#648USES AND METHODS RELATING TO NDR KINASE EXPRESSION AND/OR ACTIVITY
#649In vitro depletion of acute myeloid leukemia stem cells
#650Purinergic (P2X) receptors in extra-cellular body fluid
#651DNA FRAGMENTATION ASSAY
#652Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#653Treatment of leukemias and chronic myeloproliferative diseases with antibodies to EphA3
#654Phosphorylation and regulation of AKT/PKB by the rictor-mTOR complex
#655METHODS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA
#656Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
#657Epigenetic silencing of tumor suppressor genes
#658Classification of Patients Having Diffuse Large B-cell Lymphoma Based upon Gene Expression
#659Methods of detecting and monitoring cancer using 3D analysis of centromeres
#660Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing
#661Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#662Modulation of NR2F6 and methods and uses thereof
#663CANCER DIAGNOSIS USING KI-67
#664BCR-ABL variants
#665METHODS INVOLVING LEF-1 REGULATION AND USE OF LEF-1 OR COMPOUNDS ALTERING LEF-1 SIGNALLING FOR TREATING OR PREVENTING DISEASES
#666Methods for identifying stem cells expressing breast cancer resistance protein (BCRP)
#667PROTEINS
#668PROTEINS
#669Protein
#670PHOSPHO-SPECIFIC ANTIBODIES TO FLT3 (TYR969) AND USES THEREOF
#671Tyrosine phosphorylation sites
#672Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment
#673Methods for Identifying Compounds that Modulate WNT Signaling in Cancer Cells
#674Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
#675Methods and compounds for lymphoma cell detection and isolation
#676Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of B-chronic lymphocytic leukaemia
#677Hematopoietic cell phenotyping using circulating cell-free markers
#678GAINAC SPECIFIC BINDING MOLECULES AND USES THEREOF
#679Methods and compositions for inhibiting the growth of hematopoietic malignant cells
#680Reagents for the detection of protein phosphorylation in signaling pathways
#681Methods for diagnosis, prognosis and methods of treatment
#682METHOD FOR THE DIAGNOSIS OF LEUKEMIA
#683CCN3 peptide
#684NOVEL SIGNATURE SELF RENEWAL GENE EXPRESSION PROGRAMS
#685BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death
#686Method and probes for the detection of a tumor-specific fusion protein
#687Tyrosine phosphorylation sites
#688Anti-CD38 antibodies for the treatment of cancer
#689Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof
#690Methods for Identifying Compounds that Affect Expression of Cancer-Related Protein Isoforms
#691METHOD AND SYSTEM FOR SELECTING CHEMOTHERAPEUTIC AGENTS
#692METHODS OF DETERMINING THE HEALTH STATUS OF AN INDIVIDUAL
#693Reagents for the Detection of Protein Phosphorylation in Leukemia Signaling Pathways
#694Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
#695Acute Myelogenous Leukemia Biomarkers
#696MDA-7 PROTEINS AND METHODS OF USE THEREOF
#697UHRF1 DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#698TTK DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#699Elastase inhibitor and acute leukemia
#700Quantification of fusion proteins and their activity from chromosomal translocation
#701Reagents for the detection of protein phosphorylation in leukemia signaling pathways
#702Novel therapeutic targets in cancer
#703Diagnosis and Therapy of Cell Proliferative Disorders Characterized by Resistance to Trail Induced Apoptosis
#704MOLECULAR SIGNALING PATHWAYS TRIGGERED BY RITUXIMAB: PROGNOSTIC, DIAGNOSTIC, AND THERAPEUTIC USES
#705ORGANIC COMPOUNDS
#706Combination of FcγRIIB-specific antibodies and CD20-specific antibodies and methods of use thereof
#707Model for studying the role of genes in chemoresistance
#708Chimeric, human and humanized anti-granulocyte antibodies and methods of use
#709Antibodies to NTB-A
#710Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1
#711BAALC EXPRESSION AS A DIAGNOSTIC MARKER FOR ACUTE LEUKEMIA
#712Identification of a JAK2 mutation in polycythemia vera
#713JAB1 as a prognostic marker and a therapeutic target for human cancer
#714BIOMARKERS FOR PREDICTING THE SENSITIVITY OF CELLS TO IMMUNOMODULATORY COMPOUNDS DURING TREATMENT OF NON-HODGKIN'S LYMPHOMA
#715Chronic lymphocytic leukemia prognosis and treatment
#716Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same
#717Methods for diagnosis prognosis and methods of treatment
#718Tyrosine phosphorylation sites
#719METHODS OF THERAPY AND DIAGNOSIS USING TARGETING OF CELLS THAT EXPRESS KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR-LIKE PROTEINS
#720Human FGF-21 gene and gene expression products
#721Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#722Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
#723Tyrosine phosphorylation sites
#724Anti-IgSF4 antibody and utilization of the same
#725Novel methylation marker
#726Cancer Antigen Mage-A9 and Uses Thereof
#727Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#728Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#729NOVEL ARTEMIS/DNA-DEPENDENT PROTEIN KINASE COMPLEX AND METHODS OF USE THEREOF
#730METHOD FOR TAILORING ADMINISTRATION OF DRUGS BY QUANTITATION OF MRNA
#731Therapeutic and Prognostic Factor Yy1 in Human Cancer
#732Detection of gleevec resistance
#733Methods and Materials for Examining the P13k/Akt Pathway in Gliomas and Prostate Cancers
#734Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof
#735METHOD FOR TREATING CHRONIC LYMPHOID LEUKEMIA
#736IRTA2 antibodies and methods of use
#737Methods and Systems for Diagnosis, Prognosis and Selection of Treatment of Leukemia
#738Compositions and Methods for Differential Diagnosis of Chronic Lymphocytic Leukemia
#739Mer Diagnostic and Therapeutic Agents
#740Slitrks as markers for stem and progenitor cells and methods of use thereof
#741Methods for reducing graft-versus-host disease using pluri-differentiated mesenchymal progenitor cells
#742Reagents for the detection of protein phosphorylation in leukemia signaling pathways
#743Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)
#744ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)
#745Assay for response to proteasome inhibitors
#746Methods of detecting chronic lymphocytic leukemia with Hsp90 and ZAP-70
#747Identification and isolation of acute myeloid leukemia stem cells
#748Identification and isolation of transitional cell carcinoma stem cells
#749METHODS AND KITS FOR DIAGNOSING AND TREATING B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
#750Modified PSMA ligands and uses related thereto
#751Method of detecting or monitoring a malignant plasma cell disease
#752Diagnosis and Treatment of Myeloid and Lymphoid Cell Cancers
#753ANTI-TENASCIN MONOCLONAL ANTIBODY IMMUNOASSAYS AND DIAGNOSTIC KITS
#754Products and methods for single parameter and multiparameter phenotyping of cells
#755PROTEASOMAL PEPTIDASE ACTIVITY AND THE USE THEREOF IN CLINICAL APPLICATIONS
#756Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#757Uses of selective inhibitors of HDAC8 for treatment of T-cell proliferative disorders
#758Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#759Compositions And Methods Relating To Mammalian Internal Ribosome Entry Sites
#760Detection of gleevec resistant mutations
#761Identification of a JAK2 mutation in Polycythemia Vera
#762MARKERS FOR THE DIAGNOSIS OF AML, B-ALL AND T-ALL
#763Compositions and methods for the diagnosis and treatment of cancer
#764Cell Surface Protein Associated with Human Chronic Lymphocytic Leukemia
#765Early detection of hemangiosarcoma and angiosarcoma
#766Reverse Phase Protein Array, Protein Activation and Expression Signatures, and Associated Methods
#767Chronic lymphocytic leukaemia
#768Identification, isolation and elimination of cancer stem cells
#769Assessing Cancer And Vimentin
#770Methods for Diagnosis and Prognosis of Malignant Lymphoma
#771Polymer backbone element tags
#772APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCER
#773Method for Distinguishing Aml-Specific Flt3 Length Mutations From Tkd Mutations
#774Methods for Diagnosis of Acute Myeloid Leukemia
#775T1 Receptor-Like Ligand II and Uses Thereof
#776Method for Distinguishing Aml Subtypes With Aberrant and Prognostically Intermediate Karyotypes
#777Novel Therapeutic Targets in Cancer
#778Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3
#779Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
#780PROGNOSTIC MARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA
#781Human FGF-21 gene and gene expression products
#782Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
#783Novel therapeutic targets in cancer
#784Method for Distinguishing T(11Q23)/Mll-Positive Leukemias From t(11Q23)/Mll Negative Leukemia
#785Method For Distinguishing Cbf-Positive Aml Subtypes From Cbf-Negative Aml Subtypes
#786Method For Distinguishing Mll-Ptd-Positive Aml From Other Aml Subtypes
#787Therapeutic targets in cancer
#788Methods and compounds for lymphoma cell detection and isolation
#789Method For Distinguishing Immunologically Defined All Subtype
#790CD38 as a prognostic indicator in B cell chronic lymphocytic leukemia
#791Chimeric, human and humanized anti-granulocyte antibodies and methods of use
#792Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)
#793MOLECULAR SIGNALING PATHWAYS TRIGGERED BY RITUXIMAB: PROGNOSTIC, DIAGNOSTIC, AND THERAPEUTIC USES
#794Therapeutic targets in cancer
#795Method for distinguishing who classified aml subtypes
#796Human FGF-21 gene and gene expression products
#797Method for distinguishing aml subtypes with different gene dosages
#798Methods for distinguishing prognostically definable aml
#799Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers
#800Method for distinguishing aml subtypes with recurring genetic aberrations
#801Method for distinguishing leukemia subtypes
#802Novel compositions and methods in cancer
#803Method for diagnosing chronic myeloid leukemia
#804Quantitative ZAP-70 assay
#805Detection of gleevec resistant mutations
#806Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance
#807Novel genetic markers for leukemias
#808Mammalian IAP gene family, primers, probes and detection methods
#809Novel compositions and methods for lymphoma and leukemia
#810Antitumor antibodies, proteins, and uses thereof
#811Mammalian IAP gene family, primers, probes and detection methods
#812Antitumor antibodies, proteins, and uses thereof
#813Mammalian IAP gene family, primers, probes and detection methods
#814Hematopoietic cell phenotyping using free circulating cellular markers
#815Mammalian IAP gene family, primers, probes and detection methods
#816Mammalian IAP gene family, primers, probes and detection methods
#817Mammalian IAP gene family, primers, probes and detection methods
#818Mammalian IAP gene family, primers, probes and detection methods
#819Mammalian IAP gene family, primers, probes and detection methods
#820Classification of patients having diffuse large b-cell lymphoma based upon gene expression
#821Differentially expressed genes in large granular lymphocyte leukemia
#822Method for screening candidate compounds for antitumor drug
#823Mammalian IAP gene family, primers, probes, and detection methods
#824Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism
#825Signature genes in chronic myelogenous leukemia
#826Identification of a JAK2 mutation involved in Vaquez Polyglobulia
#827Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia
#828Methods for the identification, assessment, and treatment of patients with cancer therapy
#829Acute myelogenous leukemia biomarkers
#830Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
#831Novel therapeutic targets in cancer
#832Methods and kits for diagnosing and monitoring hematopoietic cancers
#833Mammalian IAP gene family, primers, probes and detection methods
#834Methods for diagnosing htlv-i-mediated diseases
#835miR-155 assay
#836Novel therapeutic targets in cancer
#837Methods for detecting TAFIa or TAFIai
#838Method for detecting low levels of a fusion protein
#839Replication protein
#840Novel compositions and methods in cancer
#841Organic compounds
#842Use of the slug gene, or of the transcription or expression products thereof in the detection and/or treatment of cancerous cells
#843Mammalian IAP gene family, primers, probes, and detection methods
#844Eph receptor tumor biomarkers
#845Anti-tenascin monoclonal antibody immunoassays and diagnostic kits
#846Span-xb gene and protein for the diagnosis and treatment of cancer
#847Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor
#848Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction
#849Compositions and methods for the detection diagnosis and therapy of hematological malignancies
#850Methods for diagnosis and prognosis of cancer
#851Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
#852Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#853MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia
#854Human chemokine β-9 viral vectors
#855MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia
#856Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#857Structure of protein kinase C theta
#858Novel tumor suppressor gene and compositions and methods for making and using the same
#859Method and probes for the detection of a tumor specific fusion protein
#860Modified PSMA ligands and uses related thereto
#861Antibodies to human chemokine beta-9
#862Elisa assay of serum soluble cd22 to assess tumor burnden/relapse in subjects with leukemia and lymphoma
#863Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins
#864Antibodies specific for BCR-ABL fusion protein and uses thereof
#865Fast microarray expression data analysis method for network exploration
#866Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
#867Novel therapeutic targets in cancer
#868Monoclonal antibodies recognizing BAG3 protein sequences and their use in diagnostic and therapy of cell death-involving diseases
#869Method for examining WT1-related disease
#870Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#871Chronic lymphocytic leukemia cell line
#872Therapeutic targets in cancer
#873Products and methods for single parameter and multiparameter phenotyping of cells
#874Classification of patients having diffuse large B-cell lymphoma based upon gene expression
#875Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
#876Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
#877JAB1 as a prognostic marker and a therapeutic target for human cancer
#878Method for enhancing engraftment of cells using mesenchymal progenitor cells
#879Human FGF-21 gene and gene expression products
#880Antitumor antibodies, proteins, and uses thereof
#881Use of JAG2 expression in diagnosis of plasma cell disorders
#882Depleting tumor-specific tregs